Cite
HARVARD Citation
Allegretti, J. et al. (n.d.). P378 Rectal bleeding and stool frequency improvement with tofacitinib dose escalation to, 10 mg BID in patients with Ulcerative Colitis following loss of response on tofacitinib, 5 mg BID maintenance therapy: Results from OCTAVE Open. Journal of Crohn's and colitis. pp. i380-i381. [Online].